Hans C Rumke

Summary

Publications

  1. pmc Varicella vaccination in Europe - taking the practical approach
    Paolo Bonanni
    Department of Public Health, University of Florence, Florence, Italy
    BMC Med 7:26. 2009
  2. ncbi [Chickenpox: sufficient reasons for the introduction of vaccination]
    H Rumke
    Vaxinostics Universitair Vaccincentrum Rotterdam Nijmegen, p a Erasmus MC, kamer Ee1931, Postbus 2040, 3000 CA Rotterdam
    Ned Tijdschr Geneeskd 150:2630-2. 2006
  3. doi Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
    Hans C Rumke
    Vaxinostics BV, University Vaccine Center Rotterdam Nijmegen, Beursplein 37, PO Box 30142, 3001 DC Rotterdam, The Netherlands
    Vaccine 26:2378-88. 2008
  4. doi Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses
    H C Rumke
    Vaxinostics BV, University Vaccine Center Rotterdam Nijmegen, Rotterdam, The Netherlands
    Vaccine 29:3842-9. 2011
  5. ncbi [Vaccination against chickenpox, shingles and rotavirus-infection]
    Nico G Hartwig
    Erasmus Medisch Centrum Sophia, Rotterdam, The Netherlands
    Ned Tijdschr Geneeskd 153:A913. 2009
  6. pmc The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey
    Judith H Wolleswinkel-van den Bosch
    Pallas, Health Research and Consultancy BV, Rotterdam, The Netherlands
    BMC Infect Dis 11:320. 2011

Collaborators

Detail Information

Publications6

  1. pmc Varicella vaccination in Europe - taking the practical approach
    Paolo Bonanni
    Department of Public Health, University of Florence, Florence, Italy
    BMC Med 7:26. 2009
    ....
  2. ncbi [Chickenpox: sufficient reasons for the introduction of vaccination]
    H Rumke
    Vaxinostics Universitair Vaccincentrum Rotterdam Nijmegen, p a Erasmus MC, kamer Ee1931, Postbus 2040, 3000 CA Rotterdam
    Ned Tijdschr Geneeskd 150:2630-2. 2006
    ..Ten years after the introduction of varicella vaccination in the United States of America, the incidence of complications has decreased impressively. An effect on the incidence of herpes zoster has not (yet) been seen...
  3. doi Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
    Hans C Rumke
    Vaxinostics BV, University Vaccine Center Rotterdam Nijmegen, Beursplein 37, PO Box 30142, 3001 DC Rotterdam, The Netherlands
    Vaccine 26:2378-88. 2008
    ..The safety and reactogenicity profile of the AS-H5N1 candidate vaccine can be considered clinically acceptable in the context of its use against pandemic influenza...
  4. doi Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses
    H C Rumke
    Vaxinostics BV, University Vaccine Center Rotterdam Nijmegen, Rotterdam, The Netherlands
    Vaccine 29:3842-9. 2011
    ....
  5. ncbi [Vaccination against chickenpox, shingles and rotavirus-infection]
    Nico G Hartwig
    Erasmus Medisch Centrum Sophia, Rotterdam, The Netherlands
    Ned Tijdschr Geneeskd 153:A913. 2009
    ..In the Netherlands about 3400 children are hospitalised each year for rehydration following rotavirus infection. The vaccine is given orally...
  6. pmc The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey
    Judith H Wolleswinkel-van den Bosch
    Pallas, Health Research and Consultancy BV, Rotterdam, The Netherlands
    BMC Infect Dis 11:320. 2011
    ..Most data on the burden of varicella stem from health service databases. This study aims to provide insight in the burden of varicella from a parent's perspective including cases outside the healthcare system...